arrow
Back
L

Lewis J. Rubin

University of California System

104H-index
853Paper Count
6.0WCitation Count
Published Papers 184
Publication Date
errShare
errSave
Long-Term Safety, Tolerability and Survival in Patients with Pulmonary Arterial Hypertension Treated with Macitentan: Results from the SERAPHIN Open-Label Extension
err2022-07-12
err6
errOAAI
errSouza, Rogerio; Delcroix, Marion; Galie, Nazzareno; Jansa, Pavel; Mehta, Sanjay; Pulido, Tomas; Rubin, Lewis; Sastry, B. K. S.; Simonneau, Gerald; Sitbon, Olivier; Torbicki, Adam; Boyanova, Neli; Chamitava, Liliya; Stein, Claudia; Channick, Richard N.
errShare
errSave
The impact of comorbidities on selexipag treatment effect in patients with pulmonary arterial hypertension: insights from the GRIPHON study
err2021-11-21
err33
errOAAI
errRosenkranz, Stephan; Channick, Richard; Chin, Kelly M.; Jenner, Bartosz; Gaine, Sean; Galie, Nazzareno; Ghofrani, Hossein-Ardeschir; Hoeper, Marius M.; McLaughlin, Vallerie V.; Du Roure, Camille; Rubin, Lewis J.; Sitbon, Olivier; Tapson, Victor; Lang, Irene M.
errShare
errSave
The physiological basis of pulmonary arterial hypertension
err2021-11-04
err102
errOAAI
errNaeije, Robert; Richter, Manuel J.; Rubin, Lewis J.
errShare
errSave
Long-Term Survival, Safety and Tolerability with Selexipag in Patients with Pulmonary Arterial Hypertension: Results from GRIPHON and its Open-Label Extension
err2021-10-30
err17
errOAAI
errGalie, Nazzareno; Gaine, Sean; Channick, Richard; Coghlan, J. Gerry; Hoeper, Marius M.; Lang, Irene M.; McLaughlin, Vallerie V.; Lassen, Cheryl; Rubin, Lewis J.; Hsu Schmitz, Shu-Fang; Sitbon, Olivier; Tapson, Victor F.; Chin, Kelly M.
errShare
errSave
Relationship Between Time From Diagnosis and Morbidity/Mortality in Pulmonary Arterial Hypertension Results From the Phase III GRIPHON Study
errCHEST
IF8.6
err2021-07-01
err25
errOAAI
errGaine, Sean; Sitbon, Olivier; Channick, Richard N.; Chin, Kelly M.; Sauter, Rafael; Galie, Nazzareno; Hoeper, Marius M.; McLaughlin, Vallerie V.; Preiss, Ralph; Rubin, Lewis J.; Simonneau, Gerald; Tapson, Victor; Ghofrani, Hossein-Ardeschir; Lang, Irene
errShare
errSave
Comparative bioavailability of inhaled treprostinil administered as LIQ861 and Tyvaso® in healthy subjects
err2021-06-01
err7
PREAI
errRoscigno, Robert F.; Vaughn, Toby; Parsley, Ed; Hunt, Thomas; Eldon, Michael A.; Rubin, Lewis J.
errShare
errSave
`She was like, I'm done. I'm not taking this anymore' : Health care provider perspectives about breast cancer survivors' nonadherence to adjuvant endocrine therapy
err2020-06-01
err0
PREAI
errFelder, Tisha M.; Heiney, Sue P.; Rubin, L.; Friedman, Daniela B.; Franco, Regina; Hebert, James R.; Ford, Marvella E.
errShare
errSave
Patients with pulmonary arterial hypertension with and without cardiovascular risk factors: Results from the AMBITION trial
err2019-12-01
err77
errOAAI
errMcLaughlin, Vallerie V.; Vachiery, Jean-Luc; Oudiz, Ronald J.; Rosenkranz, Stephan; Galie, Nazzareno; Barbera, Joan A.; Frost, Adaani E.; Ghofrani, Hossein-Ardeschir; Peacock, Andrew J.; Simonneau, Gerald; Rubin, Lewis J.; Blair, Christiana; Langley, Jonathan; Hoeper, Marius M.
errShare
errSave
Pulmonary artery denervation using catheter-based ultrasonic energy
err2019-10-01
err20
PREAI
errRothman, Alexander; Jonas, Michael; Castel, David; Tzafriri, Abraham Rami; Traxler, Hannes; Shav, Dalit; Leon, Martin; Ben-Yehuda, Ori; Rubin, Lewis
errShare
errSave
Efficacy and safety of ralinepag, a novel oral IP agonist, in PAH patients on mono or dual background therapy: results from a phase 2 randomised, parallel group, placebo-controlled trial
err2019-08-07
err38
errOAAI
errTorres, Fernando; Farber, Harrison; Ristic, Arsen; McLaughlin, Vallerie; Adams, John; Zhang, Jinkun; Klassen, Preston; Shanahan, William; Grundy, John; Hoffmann, Ines; Cabell, Christopher; Subias, Pilar Escribano; Sood, Namita; Keogh, Anne; D'Souza, Gwyn; Rubin, Lewis
errShare
errSave
An insider view on the World Symposium on Pulmonary Hypertension
err2019-06-01
err11
errOAAI
errHumbert, Marc; Galie, Nazzareno; McLaughlin, Vallerie V.; Rubin, Lewis J.; Simonneau, Gerald
errShare
errSave
Association of N-Terminal Pro Brain Natriuretic Peptide and Long-Term Outcome in Patients With Pulmonary Arterial Hypertension: Insights From the Phase III GRIPHON Study
err2019-05-21
err67
errOAAI
errChin, Kelly M.; Rubin, Lewis J.; Channick, Richard; Di Scala, Lilla; Gaine, Sean; Galie, Nazzareno; Ghofrani, Hossein-Ardeschir; Hoeper, Marius M.; Lang, Irene M.; McLaughlin, Vallerie V.; Preiss, Ralph; Simonneau, Gerald; Sitbon, Olivier; Tapson, Victor F.
errShare
errSave
Integrating Data From Randomized Controlled Trials and Observational Studies to Assess Survival in Rare Diseases Insights From Pulmonary Arterial Hypertension
err2019-05-01
err11
errOAAI
errTorbicki, Adam; Bacchi, Marisa; Delcroix, Marion; Farber, Harrison W.; Ghofrani, Hossein-Ardeschir; Hennessy, Brian; Jansa, Pavel; Mehta, Sanjay; Perchenet, Loic; Pulido, Tomas; Rosenberg, Daniel; Rubin, Lewis J.; Sastry, B. K. S.; Simonneau, Gerald; Sitbon, Olivier; Souza, Rogerio; Wei, Lee-Jen; Channick, Richard; Benza, Raymond
errShare
errSave
Initial combination therapy with ambrisentan plus tadalafil on pulmonary arterial hypertension-related hospitalization in the AMBITION trial
err2019-02-01
err21
errOAAI
errVachiery, Jean-Luc; Galie, Nazzareno; Barbera, Joan Albert; Frost, Adaani E.; Ghofrani, Hossein-Ardeschir; Hoeper, Marius M.; McLaughlin, Vallerie V.; Peacock, Andrew J.; Simonneau, Gerald; Blair, Christiana; Miller, Karen L.; Langley, Jonathan; Rubin, Lewis J.
errShare
errSave
Clinical trial design and new therapies for pulmonary arterial hypertension
err2019-01-24
err151
errOAAI
errSitbon, Olivier; Gomberg-Maitland, Mardi; Granton, John; Lewis, Michael I.; Mathai, Stephen C.; Rainisio, Maurizio; Stockbridge, Norman L.; Wilkins, Martin R.; Zamanian, Roham T.; Rubin, Lewis J.
errShare
errSave
An overview of the 6th World Symposium on Pulmonary Hypertension
err2019-01-24
err336
errOAAI
errGalie, Nazzareno; McLaughlin, Vallerie V.; Rubin, Lewis J.; Simonneau, Gerald
errShare
errSave